TCL Archive New Government-Wide Regulatory Policy Set For Carcinogens; Industry Group Says They are Not Scientific October 5, 1979
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014
TCL Archive In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group September 17, 1976
TCL Archive Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023 December 13, 2013
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013